http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112007043-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2020-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-112007043-B |
| titleOfInvention | Drug or composition against colorectal cancer |
| abstract | The present invention provides an anti-colorectal cancer drug or composition. The present invention finds for the first time that during the occurrence and development of colorectal cancer, overexpression of small molecule RNAs with specific sequences (such as ath-miR158a or its variants) can significantly inhibit the proliferation of colorectal cancer cells and promote the apoptosis of colorectal cancer cells , so as to play a highly effective anti-tumor effect, which is of great significance for the treatment of colorectal cancer tumors. |
| priorityDate | 2020-08-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.